Cargando…
Phase 2 multicentre trial investigating intermittent and continuous dosing schedules of the poly(ADP-ribose) polymerase inhibitor rucaparib in germline BRCA mutation carriers with advanced ovarian and breast cancer
| Autores principales: | , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4984462/ https://www.ncbi.nlm.nih.gov/pubmed/27228289 http://dx.doi.org/10.1038/bjc.2016.133 |
| _version_ | 1782447967064555520 |
|---|---|
| author | Drew, Yvette Ledermann, Jonathan Hall, Geoff Rea, Daniel Glasspool, Ros Highley, Martin Jayson, Gordon Sludden, Julieann Murray, James Jamieson, David Halford, Sarah Acton, Gary Backholer, Zoe Mangano, Raffaella Boddy, Alan Curtin, Nicola Plummer, Ruth |
| author_facet | Drew, Yvette Ledermann, Jonathan Hall, Geoff Rea, Daniel Glasspool, Ros Highley, Martin Jayson, Gordon Sludden, Julieann Murray, James Jamieson, David Halford, Sarah Acton, Gary Backholer, Zoe Mangano, Raffaella Boddy, Alan Curtin, Nicola Plummer, Ruth |
| author_sort | Drew, Yvette |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4984462 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2016 |
| publisher | Nature Publishing Group |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-49844622016-08-25 Phase 2 multicentre trial investigating intermittent and continuous dosing schedules of the poly(ADP-ribose) polymerase inhibitor rucaparib in germline BRCA mutation carriers with advanced ovarian and breast cancer Drew, Yvette Ledermann, Jonathan Hall, Geoff Rea, Daniel Glasspool, Ros Highley, Martin Jayson, Gordon Sludden, Julieann Murray, James Jamieson, David Halford, Sarah Acton, Gary Backholer, Zoe Mangano, Raffaella Boddy, Alan Curtin, Nicola Plummer, Ruth Br J Cancer Corrigendum Nature Publishing Group 2016-06-14 2016-05-26 /pmc/articles/PMC4984462/ /pubmed/27228289 http://dx.doi.org/10.1038/bjc.2016.133 Text en Copyright © 2016 Cancer Research UK http://creativecommons.org/licenses/by/4.0/ This work is licensed under the Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ |
| spellingShingle | Corrigendum Drew, Yvette Ledermann, Jonathan Hall, Geoff Rea, Daniel Glasspool, Ros Highley, Martin Jayson, Gordon Sludden, Julieann Murray, James Jamieson, David Halford, Sarah Acton, Gary Backholer, Zoe Mangano, Raffaella Boddy, Alan Curtin, Nicola Plummer, Ruth Phase 2 multicentre trial investigating intermittent and continuous dosing schedules of the poly(ADP-ribose) polymerase inhibitor rucaparib in germline BRCA mutation carriers with advanced ovarian and breast cancer |
| title | Phase 2 multicentre trial investigating intermittent and continuous dosing schedules of the poly(ADP-ribose) polymerase inhibitor rucaparib in germline BRCA mutation carriers with advanced ovarian and breast cancer |
| title_full | Phase 2 multicentre trial investigating intermittent and continuous dosing schedules of the poly(ADP-ribose) polymerase inhibitor rucaparib in germline BRCA mutation carriers with advanced ovarian and breast cancer |
| title_fullStr | Phase 2 multicentre trial investigating intermittent and continuous dosing schedules of the poly(ADP-ribose) polymerase inhibitor rucaparib in germline BRCA mutation carriers with advanced ovarian and breast cancer |
| title_full_unstemmed | Phase 2 multicentre trial investigating intermittent and continuous dosing schedules of the poly(ADP-ribose) polymerase inhibitor rucaparib in germline BRCA mutation carriers with advanced ovarian and breast cancer |
| title_short | Phase 2 multicentre trial investigating intermittent and continuous dosing schedules of the poly(ADP-ribose) polymerase inhibitor rucaparib in germline BRCA mutation carriers with advanced ovarian and breast cancer |
| title_sort | phase 2 multicentre trial investigating intermittent and continuous dosing schedules of the poly(adp-ribose) polymerase inhibitor rucaparib in germline brca mutation carriers with advanced ovarian and breast cancer |
| topic | Corrigendum |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4984462/ https://www.ncbi.nlm.nih.gov/pubmed/27228289 http://dx.doi.org/10.1038/bjc.2016.133 |
| work_keys_str_mv | AT drewyvette phase2multicentretrialinvestigatingintermittentandcontinuousdosingschedulesofthepolyadpribosepolymeraseinhibitorrucaparibingermlinebrcamutationcarrierswithadvancedovarianandbreastcancer AT ledermannjonathan phase2multicentretrialinvestigatingintermittentandcontinuousdosingschedulesofthepolyadpribosepolymeraseinhibitorrucaparibingermlinebrcamutationcarrierswithadvancedovarianandbreastcancer AT hallgeoff phase2multicentretrialinvestigatingintermittentandcontinuousdosingschedulesofthepolyadpribosepolymeraseinhibitorrucaparibingermlinebrcamutationcarrierswithadvancedovarianandbreastcancer AT readaniel phase2multicentretrialinvestigatingintermittentandcontinuousdosingschedulesofthepolyadpribosepolymeraseinhibitorrucaparibingermlinebrcamutationcarrierswithadvancedovarianandbreastcancer AT glasspoolros phase2multicentretrialinvestigatingintermittentandcontinuousdosingschedulesofthepolyadpribosepolymeraseinhibitorrucaparibingermlinebrcamutationcarrierswithadvancedovarianandbreastcancer AT highleymartin phase2multicentretrialinvestigatingintermittentandcontinuousdosingschedulesofthepolyadpribosepolymeraseinhibitorrucaparibingermlinebrcamutationcarrierswithadvancedovarianandbreastcancer AT jaysongordon phase2multicentretrialinvestigatingintermittentandcontinuousdosingschedulesofthepolyadpribosepolymeraseinhibitorrucaparibingermlinebrcamutationcarrierswithadvancedovarianandbreastcancer AT sluddenjulieann phase2multicentretrialinvestigatingintermittentandcontinuousdosingschedulesofthepolyadpribosepolymeraseinhibitorrucaparibingermlinebrcamutationcarrierswithadvancedovarianandbreastcancer AT murrayjames phase2multicentretrialinvestigatingintermittentandcontinuousdosingschedulesofthepolyadpribosepolymeraseinhibitorrucaparibingermlinebrcamutationcarrierswithadvancedovarianandbreastcancer AT jamiesondavid phase2multicentretrialinvestigatingintermittentandcontinuousdosingschedulesofthepolyadpribosepolymeraseinhibitorrucaparibingermlinebrcamutationcarrierswithadvancedovarianandbreastcancer AT halfordsarah phase2multicentretrialinvestigatingintermittentandcontinuousdosingschedulesofthepolyadpribosepolymeraseinhibitorrucaparibingermlinebrcamutationcarrierswithadvancedovarianandbreastcancer AT actongary phase2multicentretrialinvestigatingintermittentandcontinuousdosingschedulesofthepolyadpribosepolymeraseinhibitorrucaparibingermlinebrcamutationcarrierswithadvancedovarianandbreastcancer AT backholerzoe phase2multicentretrialinvestigatingintermittentandcontinuousdosingschedulesofthepolyadpribosepolymeraseinhibitorrucaparibingermlinebrcamutationcarrierswithadvancedovarianandbreastcancer AT manganoraffaella phase2multicentretrialinvestigatingintermittentandcontinuousdosingschedulesofthepolyadpribosepolymeraseinhibitorrucaparibingermlinebrcamutationcarrierswithadvancedovarianandbreastcancer AT boddyalan phase2multicentretrialinvestigatingintermittentandcontinuousdosingschedulesofthepolyadpribosepolymeraseinhibitorrucaparibingermlinebrcamutationcarrierswithadvancedovarianandbreastcancer AT curtinnicola phase2multicentretrialinvestigatingintermittentandcontinuousdosingschedulesofthepolyadpribosepolymeraseinhibitorrucaparibingermlinebrcamutationcarrierswithadvancedovarianandbreastcancer AT plummerruth phase2multicentretrialinvestigatingintermittentandcontinuousdosingschedulesofthepolyadpribosepolymeraseinhibitorrucaparibingermlinebrcamutationcarrierswithadvancedovarianandbreastcancer |